A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)

Publication | Open Access

DOI Full Paper Access

Citations

References

2006

Year

Richard Booton, Paul Lorigan, Heather Anderson, Sofia Baka, Linda Ashcroft, M. Nicolson, Mary Claire O’Brien, David J. Dunlop, Kenneth J. O’Byrne, V. Laurence,

Annals of Oncology

Mitomycin C/vinblastine/cisplatinMedicineMetronomic TherapyPhase Iii TrialClinical TrialsBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerRandomised Multicentre TrialRadiologyHealth Sciences